Eczema in early childhood is strongly associated with the development of asthma and rhinitis in a prospective cohort by Laura B von Kobyletzki et al.
von Kobyletzki et al. BMC Dermatology 2012, 12:11
http://www.biomedcentral.com/1471-5945/12/11RESEARCH ARTICLE Open AccessEczema in early childhood is strongly associated
with the development of asthma and rhinitis in a
prospective cohort
Laura B von Kobyletzki1,2*, Carl-Gustaf Bornehag2, Mikael Hasselgren3,4, Malin Larsson2,
Cecilia Boman Lindström2 and Åke Svensson1Abstract
Background: This study aimed to estimate the association between eczema in early childhood and the onset of
asthma and rhinitis later in life in children.
Methods: A total of 3,124 children aged 1–2 years were included in the Dampness in Building and Health (DBH)
study in the year 2000, and followed up 5 years later by a parental questionnaire based on an International Study
of Asthma and Allergies in Childhood protocol. The association between eczema in early childhood and the
incidence of asthma and rhinitis later in life was estimated by univariable and multivariable logistic regression
modelling.
Results: The prevalence of eczema in children aged 1–2 years was 17.6% at baseline. Children with eczema
had a 3-fold increased odds of developing asthma (adjusted odds ratio [aOR], 3.07; 95% confidence interval (CI)
1.79–5.27), and a nearly 3-fold increased odds of developing rhinitis (aOR, 2.63; 1.85–3.73) at follow-up compared
with children without eczema, adjusted for age, sex, parental allergic disease, parental smoking, length of
breastfeeding, site of living, polyvinylchloride flooring material, and concomitant allergic disease. When eczema was
divided into subgroups, moderate to severe eczema (aOR, 3.56; 1.62–7.83 and aOR, 3.87; 2.37–6.33, respectively),
early onset of eczema (aOR, 3.44; 1.94–6.09 and aOR, 4.05; 2.82–5.81; respectively), and persistence of eczema (aOR,
5.16; 2.62–10.18 and aOR, 4.00; 2.53–6.22, respectively) further increased the odds of developing asthma and rhinitis.
Further independent risk factors increasing the odds of developing asthma were a parental history of allergic
disease (aOR, 1.83; 1.29–2.60) and a period of breast feeding shorter than 6 months (aOR, 1.57; 1.03–2.39). The
incidence of rhinitis was increased for parental history of allergic disease (aOR, 2.00; 1.59–2.51) and polyvinylchloride
flooring (aOR, 1.60; 1.02–2.51).
Conclusion: Eczema in infancy is associated with development of asthma and rhinitis during the following 5-year
period, and eczema is one of the strongest risk factors. Early identification is valuable for prediction of the atopic
march.Background
The prevalence of eczema has increased to levels of pub-
lic health relevance in the Western world, especially in
children [1]. As the most frequent inflammatory condi-
tion in childhood, eczema affects physiological and psy-
chological wellbeing of affected children and results in* Correspondence: laura.vonkobyletzki@liv.se
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distribution, and reproduction in any mediumsubstantial costs [2,3]. It has been suggested that early
life eczema is a risk factor for the development of
asthma later in life [4]. However, evidence for the pro-
gression to asthma comes mainly from cross-sectional
studies [5]. There are only a few prospective cohort
studies that have investigated the association between
early life eczema and later onset of asthma and rhinitis
[6-11]. Some of the existing longitudinal studies found
no association between eczema and later onset of
asthma [6-8], and other prospective studies found an ec-
zema/asthma relationship much weaker than expectedCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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explained by a different effect across eczema subgroups
on allergic airway diseases [12]. The severity of eczema
has been found to be more closely associated with the
risk of developing asthma than the timing of onset, or
duration of eczema symptoms [12-14]. We examined
whether eczema in early childhood predicts the later
onset of asthma and rhinitis in children and determined
the importance of severity, time of onset and persistency
of the childhood eczema by analysing data from a large
prospective population-based cohort with a follow-up
period of 5 years.
Methods
Data collection
The methods of the population-based Swedish Dampness
in Buildings and Health (DBH) study have been pub-
lished by Bornehag et al.. and Larsson et al. [15,16].
The DBH study started in 2000, and a questionnaire
based on an International Study of Asthma and Allergies
in Childhood (ISAAC) protocol [17] was given to par-
ents of all children aged 1 to 5 years living in the county
of Värmland (DBH-I). Follow-up was performed in
2005 in children who were aged 1 to 3 years in 2000
(DBH-III). In this study we investigated the children ini-
tially aged 1–2 years.
Four thousand and twenty children initially aged
1–2 years had answered a baseline questionnaire in 2000
based on an ISAAC protocol. The cohort of the current
study consisted of 3,124 children who responded both to
the baseline and a follow-up questionnaire in 2005
(response rate: 77.7%).
Inclusion criteria of the baseline survey were all chil-
dren living in Värmland aged 1–5 years whose parents
gave consent to participate and who answered a postal
questionnaire. The study was approved by the regional
ethical committee in Örebro.
Definition of variables
The original ISAAC questions were used. In addition,
questions on doctor-diagnosed asthma and doctor-
diagnosed rhinitis were included. The additional ques-
tions were: “Has your child been diagnosed with asthma
by a physician?” and “Has your child been diagnosed
with rhinitis by a physician?” The main outcomes were
“5-year cumulative incidence of asthma” and “5-year cu-
mulative incidence of rhinitis”. The “5-year cumulative
incidence of asthma” was defined as no report of
physician-diagnosed asthma and no wheezing at baseline
in 2000, but physician-diagnosed asthma was reported in
2005. The “5-year cumulative incidence of rhinitis” was
defined as no report of physician-diagnosed rhinitis in
2000, but physician-diagnosed rhinitis was reported in
2005.The main explanatory variable was eczema. Eczema in
early childhood was defined by affirmative responses to
the question “Has your child had an itchy rash at any
time in the last 12 months?” in the baseline question-
naire in 2000.
Secondary analysis was performed for subgroups of
eczema, persistent eczema, severe eczema and early
onset of eczema, and their association with later devel-
opment of allergic airway diseases. Persistent eczema
was assumed when children reported signs of eczema
both at baseline and at follow-up; the questions asked
were: “Has your child ever had an itchy rash (eczema)
which was coming and going for at least 6 months” and
“Has your child had this itchy rash at any time in the
last 12 months?” in 2000, and “Has your child had this
itchy rash at any time in the last 12 months?” in 2005.
The onset of eczema was determined form the question
“At what age did this itchy rash first occur?” in 2000,
and it was categorised into “early onset” if symptoms
occurred before the age of 1 year. The question “In the
last 12 months, how often, on average, has your child
been kept awake at night by eczema?” was included in
the ISAAC eczema questionnaire as a measure of the se-
verity of eczema, where sleep loss several times per week
was considered to be severe eczema [17,18]. To simplify
analysis, the severity of eczema was re-categorized,
by using “any awakening at night” as an identifier for
moderate to severe eczema, and “no awakening” was
considered to be mild eczema. Information on single
parenthood was obtained via the question “How many
adults are currently living with the child”; two adults
caring for the child could be any two adults.
Statistical analysis
The association between eczema in early childhood and
the development of asthma and rhinitis was estimated
by using univariable logistic regression and expressed as
odds ratios (ORs) with confidence intervals (CIs). Statis-
tical significance was assessed using the likelihood ratio
test (LRT; p< 0.05). Characteristics of participants and
non-participants were compared in drop-out analysis
using the chi-square test (p< 0.05). Crude analysis of
the association between all other risk factors, and
asthma and rhinitis were performed. Linear trends of
variables with several categories were evaluated. In mul-
tivariable logistic regression analysis, the ORs were
adjusted for sex, age of the child, socioeconomic vari-
ables (parental smoking, number of adults living with
the child, and type of house), and potential confounding
variables, which included all other factors (see Table 1).
The potential confounding variables were added in des-
cending order of strength of crude association (smallest
p-value first). Factors still associated with asthma and
rhinitis were kept in the model. The interaction between
Table 1 Crude associations between risk factors at baseline and the incidence of asthma and rhinitis*












No 2,573 (82.4) 101 1.0 107 1.0
Yes 551 (17.6) 49 2.85 (1.72-4.71) 65 3.14 (2.27-4.36)
Persistence of eczema <0.001
No 2,886 (92.4) 58 1.0 <0.001 135 1.0
Yes 238 (7.6) 15 4.20 (2.31-7.64) 37 3.92 (2.64-5.82)
Onset of eczema <0.001
No 2,483 (80.6) 46 1.0 <0.001 98 1.0
Age≥ one year 216 (6.9) 6 1.87 (0.7-4.45) 8 0.96 (0.46-2.00)
Age< one year 386 (12.6) 21 3.63 (2.12-6.22) 66 5.02 (3.58-7.05)
Eczema severity <0.001
No 2,478 (79.47) 45 1.0 <0.001 98 1.0
Mild 468 (15.0) 17 2.42 (1.36-4.29) 47 2.74 (1.90-3.95)
Moderate to severe 173 (5.5) 11 4.55 (2.27-9.12) 27 4.74 (2.98-7.55)
Gender 0.001
Female 1,546 (49.5) 25 1.0 0.002 65 1.0
Male 1,579 (50.5) 48 2.16 (1.32-3.54) 107 1.67 (1.21-2.29)
Age of the child 0.727
12-23 month 1,557 (49.8) 41 1.0 0.325 88 1.0
24-35 month 1,568 (50.2) 32 0.79 (0.49-1.27) 84 0.95 (0.70-1.29)
Parental history of allergic disease <0.001
No parent 1,594 (51.0) 26 1.0 <0.001 47 1.0
One parent 1,199 (38.4) 32 1.92 (1.14-3.25) 83 2.45 (1.69-3.53)
Two parents 332 (10.6) 15 (7.2) 3.67 (1.90-7.08) 42 4.85 (3.12-7.55)
Asthma in the child <0.001
No 2,843 (91.4) – – 147 1.0
Yes 269 (8.6) – – – 25 4.10 (2.57-6.54)
Length of breastfeeding 0.791
Longer than 6 month 2,043 (65.9) 44 1.0 0.021 112 1.0
Up to 6 months 974 (31.4) 23 1.14 (0.68-1.90) 54 1.02 (0.73-1.43)
No breastfeeding 82 (2.7) 6 3.32 (1.36-8.11) 6 1.35 (0.57-3.16)
Number of bedrooms with PVC 0.116
No PVC in bedroom 1,300 (42.8) 23 1.0 0.184 60 1.0
PVC in one bedroom 558 (18.4) 14 1.42 (0.72-2.79) 38 1.51 (0.99-2.30)
PVC in two bedrooms 1,183 (38.9) 34 1.65 (0.96-2.82) 70 1.31 (0.92-1.87)
Type of building 0.453
Single-family house 2,522 (82.4) 58 1.0 0.902 137 1.0
Multi-family house 538 (17.6) 12 1.04 (0.55-1.96) 33 1.13 (0.75-1.70)
Parental smoking 0.357
No 2,431 (77.8) 56 1.0 0.691 139 1.0
Yes 694 (22.2) 17 1.12 (0.64-1.94) 33 0.83 (0.56-1.23)
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Table 1 Crude associations between risk factors at baseline and the incidence of asthma and rhinitis* (Continued)
Number of adults living with the child 0.830
Two or more adults 2,853 (93.8) 66 1.0 0.320 157 1.0
One adult 190 (6.2) 6 1.54 (0.65-3.62) 11 1.07 (0.57-2.01)
3,124 children aged 1–2 in 2000 in Värmland, Sweden, were included in the analysis.
*during the 5-year follow-up period.
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subgroups of eczema on asthma and rhinitis was exam-
ined. Because of the strong association between persist-
ence, early onset and severe eczema, three adjusted
models for these groups are reported.
Clustering by families was considered. No clustering
effects were found after statistical assessment. The
results obtained using robust standard errors, general-
ised estimating equations, and random effect modelling
were similar to those obtained from the analysis of single
subjects in terms of the exposure outcome relationship,
and no evidence for significant intra-cluster correlation
was found. Therefore, ordinary logistic regression mod-
els are shown that ignore clustering. The Hosmer and
Lemeshow goodness-of-fit test statistic provided evi-
dence that the models were a good fit to the data [19].
We undertook a sensitivity analysis and used questions
that asked about symptoms of asthma/rhinitis (wheezing
and runny nose) and questions that asked about doctors’
diagnoses (asthma and rhinitis). This was performed in
case people’s perceptions of symptoms are stronger indi-
cations of health than reports of doctors’ diagnoses.Power
Assuming that 7.3% of children with eczema and 2.5% of
children without eczema develop asthma later in life,
this study had the power to detect an odds ratio of 2.8
with 96% power.
All analyses were carried out using STATA, version 11
(STATA Corp., College Station, TX).Results
The study population consisted of 3,124 children, aged
1–2 years from 2,526 families due to siblinghood. The
study population showed equal distribution regarding age
and sex. Most children were breastfed (97.4%), and living
with two adults (93.8%) in a single-family house (82.4%),
with non-smoking parents (77.8%). A high proportion of
children had at least one parent with a history of aller-
gic disease (49.0%, Table 1). In the 1–2-year-old chil-
dren, the prevalence of baseline eczema was 17.6%
(n = 551; 95% CI, 16.3–19.0%). The cumulative 5-year
incidence of asthma was 3.1 % (2.5–3.9) and rhinitis
was 5.6% (4.8–6.5).Drop out in the study
Of 4,020 children aged 1–2 years, who participated in
the baseline survey in 2000, 3,124 children participated
in the follow-up in 2005. A total of 896 children did not
continue participating in the study. There were no dif-
ferences in background (age and sex) and health factors
(prevalence of eczema, asthma, wheezing and rhinitis,
and parents with history of allergic disease) measured at
baseline between the children participating in both sur-
veys compared with the “drop-outs” (p> 0.05). However,
there was a higher prevalence of socioeconomic risk fac-
tors, parental smoking (30.5% vs. 22.2%; p< 0.001), one
adult living with a child (11.1% vs. 6.2%; p< 0.001), and
living in a multifamily house (27.0% vs. 17.6%; p
< 0.001) in drop-outs compared with that in
participants.Odds of developing asthma and rhinitis
Unadjusted analyses showed that children with eczema
at baseline had more than a 2-fold increase in the
odds of developing asthma (OR, 2.85; 95% CI, 1.72–
4.71) and a 3-fold increase in the odds of developing
rhinitis (OR, 3.14; 2.27–4.36) compared with children
without eczema at baseline. The odds for developing
asthma and rhinitis remained increased after adjust-
ment (aOR, 3.07; 1.79–5.27 and aOR, 2.63; 1.85–3.73,
respectively) for eczema, sex, age, family history of
allergic disease, asthma, length of breastfeeding,
PVC-flooring material in the home, type of building,
environmental tobacco smoke, and number of adults
living with the child (Table 2).Different subgroups of children with eczema
In adjusted analysis, children with persistence of ec-
zema, early onset of eczema, or moderate to severe ec-
zema had even higher odds of developing asthma and
rhinitis than children with eczema in general. The odds
of developing asthma and rhinitis was 5-fold in chil-
dren with persistence of eczema compared with the ab-
sence of eczema (aOR, 5.16; 2.62–10.18 and aOR, 4.00;
2.53–6.22, respectively). Early onset of eczema was a
strong risk factor for the incidence of asthma (aOR,
3.44; 95% CI, 1.94–6.09) and the incidence of rhinitis
(aOR, 4.05; 95% CI, 2.82–5.81) compared with children
without eczema, whereas there was no significant
Table 2 Factors associated with the 5-year cumulative incidence of asthma and incidence of rhinitis in eczema patients
aged 1–2 years in Sweden
Risk factor at baseline Incidence of asthma (N=2063) Incidence of rhinitis (N= 2751)
Adjusted odds ratio*
(95% confidence interval)
P-value Adjusted odds ratio*
(95% confidence interval)
P-value
Eczema at baseline <0.001
No 1.0 <0.001 1.0
Yes 3.07 (1.79-5.27) 2.63 (1.85-3.73)
Gender 0.006
Female 1.0 0.003 1.0
Male 2.20 (1.30-3.72) 1.59 (1.14- 2.23)
Age of the child 0.290
12-23 month 1.0 0.340 1.0
24-35 month 0.78 (0.47-1.30) 0.84 (0.60-1.16)
Parental history of allergic disease& <0.001
No parent with allergic disease 1.0 <0.001 1.0
Parent(s) with history of
allergic disease
1.83 (1.29-2.60) 2.00 (1.59-2.51)
Asthma in the child <0.001
No – – 1.0
Yes 2.80 (1.66-4.70)
Breastfeeding&& 0.446
Breastfeeding longer than 6 month 1.0 0.044 1.0
Breastfeeding up to 6 month 1.57 (1.03-2.39) 1.13 (0.83-1.54)
Number of bedrooms with PVC 0.106
No PVC in bedroom 1.0 0.288 1.0
PVC in one bedroom 1.36 (0.65-2.83) 1.60 (1.02- 2.51)
PVC in two bedrooms 1.57 (0.89-2.78) 1.30 (0.90-1.90)
Type of dwelling 0.546
Single family house 1.0 0.605 1.0
Multi family house 1.21 (0.60-2.44) 1.15 (0.73-1.81)
Smoking by parents 0.707
No 1.0 0.810 1.0
Yes 0.92 (0.47-1.79) 0.92 (0.60-1.42)
Number of adults living with the child 0.942
Two or more 1.0 0.208 1.0
One 0.43 (0.10-1.81) 1.03 (0.50-2.11)
*Adjusted by logistic regression for all other variables listed in the table.
&linear effect aOR, with reference category no parent; other categories one parent, and two parents.
&& linear effect aOR, with reference category longer than 6 months; other categories up to 6 months, and no breastfeeding.
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incidence of asthma (aOR, 2.07; 0.78–5.49) and rhinitis
(aOR, 0.96; 0.45–2.03). Both mild and moderate to se-
vere eczema were associated with the incidence of
asthma and rhinitis compared with children without
eczema, with a higher odds of developing asthma and
rhinitis in moderate to severe eczema (aOR, 3.56; 1.62–
7.83 and aOR, 3.87; 2.37–6.33, respectively) than mild
eczema compared with children without eczema (aOR,2.85; 1.57–5.19 and aOR, 2.37; 1.60–3.51, respectively)
(Table 3).
Other risk factors for development of asthma and rhinitis
during a 5-year period
In adjusted analysis, a parental history of allergic disease
increased the odds of developing asthma and rhinitis by
2-fold. The odds of developing asthma was 2-fold and
that of developing rhinitis was 59% higher in boys
Table 3 Subgroups of eczema in children and the 5-year cumulative incidence of asthma and rhinitis$
Eczema group Crude OR (95% CI) P-value Adjusted OR# (95% CI) P-value
Incidence of asthma (N = 2063)
Duration of eczema
Never eczema 1.0 <0.001 1.0 <0.001
Eczema only in 2000 1.94 (0.93-4.06) 2.17 (1.01-4.65)
Eczema only in 2005 1.97 (0.94- 4.13) 1.77 (0.77-4.11)
Persistence of eczema## 4.95 (2.65-9.25) 5.16 (2.62-10.18)
Onset of eczema
Late onset of eczema### 1.87 (0.78-4.45) <0.001 2.07 (0.78-5.49) <0.001
Early onset of eczema ### 3.63 (2.12-6.22) 3.44 (1.94-6.09)
Severity of eczema
Mild eczema### 2.42 (1.36-4.29) <0.001 2.85 (1.57-5.19) <0.001
Moderate to severe eczema ### 4.55 (2.27-9.11) 3.56 (1.62-7.83)
Incidence of rhinitis (N = 2751)
Duration of eczema
No eczema 1.0 <0.001 1.0 <0.001
Eczema only in 2000 2.52 (1.61-3.94) 2.25 (1.40-3.61)
Eczema only in 2005 1.96 (1.20-3.21) 2.00 (1.19-3.37)
Persistence of eczema## 4.91 (3.23-7.46) 4.00 (2.53-6.22)
Onset of eczema
Late onset of eczema### 0.96 (0.46-2.00) <0.001 0.96 (0.45-2.03) <0.001
Early onset of eczema ### 5.02 (3.58-7.05) 4.05 (2.82-5.81)
Severity of eczema
Mild eczema### 2.74 (1.90-3.95) <0.001 2.37 (1.60-3.51) <0.001
Moderate to severe eczema### 4.74 (2.98-7.55) 3.87 (2.37-6.33)
$ If not otherwise stated, the comparisons are dichotomous with the referent category being the low-odds group (aOR= 1), and the high-odds group data shown
in the table.
#Adjustments were made for gender, age, family history of allergic disease, asthma, length of breastfeeding, PVC-flooring material in the home, type of building,
environmental tobacco smoke, and number of adults living with the child.
## Defined as eczema ever for at least 6 months, and current eczema in both 2000 and 2005.
### no eczema in 2000 as reference.
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of developing rhinitis by nearly 3-fold, and a period of
breastfeeding shorter than 6 months increased the risk
of developing asthma by 57% (Table 2). PVC-flooring
material in the bedroom increased the incidence of
asthma and rhinitis, but statistical significance was only
reached for the relationship between PVC flooring-
material and rhinitis. Interestingly, PVC-flooring mater-
ial had a higher effect on girls for the incidence of
asthma and rhinitis in all models (data not shown).
Interactions between eczema and sex were explored and
there was no effect of eczema on the incidence of
asthma and rhinitis across sex strata (interaction p-
values: 0.747 for asthma and 0.664 for rhinitis).
Sensitivity analysis
For assessing the relationships between asthma and
rhinitis and remission, we used different assessments ofasthma and rhinitis to ensure that the relationship was
stable and not dependent on which questions were used.
We used both reports of symptoms and reports of doc-
tors’ diagnoses. Both of these reports were similar in
both crude and adjusted analysis; eczema increased the
odds of developing rhinitis symptoms (OR, 2.81; 2.23–
3.55 and aOR, 2.39; 1.86–3.08) and wheezing symptoms
(OR, 2.10; 1.37–3.23 and aOR, 1.97; 1.24–3.12).
Discussion
Our study found that eczema in early childhood was
strongly associated with the development of asthma and
rhinitis during the following 5-year period. Eczema was
one of the strongest independent risk factors. Interest-
ingly, when eczema was divided into subgroups, children
with early onset of eczema, moderate to severe eczema,
and persistence of eczema had the highest odds of devel-
oping asthma and rhinitis.
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that early eczema affects later development of asthma
and rhinitis.
Although some previous prospective studies were not
able to show an association between early childhood ec-
zema and later development of asthma and rhinitis [6,8],
our findings are robust and in line with the study by
Arshad et al [9]. In addition, similar results regarding se-
verity have been found in both Gustavsson’s and Ricci’s
eczema cohorts [12,13], which reported that eczematous
children with high severity scores were at increased risk
of developing asthma. To the best of our knowledge, our
study is the first prospective cohort to show that early
onset of eczema or persistent eczema increases the odds
of later onset of asthma in both boys and girls, which is
in contrast to a previous study that only showed a rela-
tionship in boys [20]. Definitions of asthma and rhinitis
are important for the interpretation of results [15]. Our
sensitivity analysis confirmed that the association be-
tween eczema and asthma/rhinitis remained when
symptom-based criteria for asthma and rhinitis were
used.
Possible explanations for the relationship between
eczema and asthma and rhinitis
Evidence from several experimental studies has sug-
gested that impaired epithelial function results in
increased sensitization and IgE production [21]. In
humans, the theory of epicutaneous sensitization is sup-
ported by the observation that exposing atopic children
to topical emollients containing peanut protein leads to
an increased risk of airway peanut sensitization [22].
Genetic factors, such as the common loss of function
mutations within the filaggrin gene, are a risk factor for
incident eczema and account for skin barrier dysfunc-
tion [23,24]. Recently, it has been shown that filaggrin
mutations affect asthma, which supports the hypothesis
that impaired skin function acts as a gateway for aller-
gens, increasing the risk of atopic airways diseases [25].
Advantages and limitations
A major advantage of our study was its prospective de-
sign, which made results less subject to recall bias and
allowed assessment of temporal relationships. Our study
had a large sample size compared with earlier studies
[6,8]. Our results should be less prone to selection and
ascertainment bias because of its population-based de-
sign. We also had a high response rate and limited loss
to follow-up. There were no differences between the
analysed sample and drop-outs in health-related vari-
ables; therefore results might have been biased towards
1. A higher prevalence of socioeconomic risk factors in
children leaving the study, while assuming that low
socioeconomic status is a risk factor for the incidence ofasthma, might have biased the results towards 1 as well.
Therefore, our conclusions that eczema is associated
with later onset of asthma and rhinitis would not change
if all children had participated. The advantages of the
study design and performance allow generalization of
results.
Reporting of eczema by questionnaire might have
advantages compared with assessment by physicians, be-
cause eczema can be intermittent [26]. The term “itchy
flexural rash in the last 12 months” has been shown to
correlate well with diagnosis by a physician in a validation
study performed in the UK on children aged 3–11 years
[18]. Sensitivity in this previous study was 84% and specifi-
city was 93% [18]. In addition, the ISAAC eczema ques-
tionnaire has been used for studies on pre-school children
[26]. Although questions for diagnosis have been validated
for eczema in 4–11-year-olds and for asthma in children
aged 1–6 years [27], the ISAAC questionnaire has not
been validated for parental information regarding pre-
school children. However, we consider that it is unlikely
that there was differential misclassification; random mis-
classification would mean that any bias in our estimates
was towards null.
Currently, there is no clear definition of persistence of
eczema, which is consistent as reported by Williams
[28]. Illi [7] and Möhrenschlager [29] considered eczema
as persistent when signs of the disease were present at
different points of time. In our study, persistence of ec-
zema was defined as having had eczema at least three
times. Therefore, the risk of including children with
“short-term rashes only” might be low, but we cannot
exclude the possibility that some children classified as
having persistent eczema had longer symptom-free
intervals. It would have been advantageous to assess the
prevalence of eczema more often during the study
period.
Implications
Based on the results of our study, further evidence is
required to unravel the underlying mechanisms of ec-
zema in early childhood leading to asthma. Although we
confirmed a relationship between childhood eczema and
incident asthma and rhinitis, the association between
childhood eczema and later asthma and rhinitis might
still be separate and sequential, but are otherwise unre-
lated in the background of an atopic phenotype. Because
the relationship between childhood eczema and incident
asthma and rhinitis was temporal, strong, and linear, our
findings suggest that the relationship might be causal. In
this regard, impaired skin function might hypothetically
be one explanatory factor [21], and the effect of early
and successful treatment of eczema should be explored
regarding the incidence of asthma as one outcome
measure [30,31]. Further, it might be beneficial to
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fies or confounds the eczema/asthma relationship in fu-
ture studies. Our study results have important
implications for patient management since asthma can
lead to high impairment and costs.
Conclusions
Eczema in infancy independently increases the odds of
developing asthma and rhinitis during the following 5-
year period. This association is present for children with
eczema at baseline; however when they are divided into
subgroups (severe eczema, early onset of eczema and
persistence of eczema) the odds of the incidence of
asthma and rhinitis further increases. Identifying risk
groups is important for healthcare planning.
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